Meng Qiu
Academic / Other · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study Colorectal Cancer | Phase 2 | 2026-04-27 |
| Not Yet Recruiting | First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Colorectal Cancer (CRC), Capecitabine, Cetuximab | Phase 3 | 2024-09-26 |
| Recruiting | Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC Fruquintinib, S-1, Raltitrexed | Phase 2 | 2023-02-20 |
| Active Not Recruiting | HAIP Combined With Fuquinitinib as Late-line Treatment in Patients With CRLM：A Phase 2 Single-Arm Clinical Tri Colorectal Neoplasms | Phase 2 | 2023-01-12 |
| Unknown | The Efficacy and Safety of a Compound Glutamine Capsule in the Primary Prevention of Chemotherapy-induced Muco Mucositis, Chemotherapeutic Toxicity | Phase 3 | 2021-06-30 |
| Unknown | The Efficacy and Safety of a Compound Glutamine Capsule in the Prevention of Chemotherapy-induced Mucositis Mucositis, Chemotherapeutic Toxicity | Phase 3 | 2021-06-30 |